Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Faster, Cleaner, Better.

Kiora Pharmaceuticals Inc. (KPRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2015	12-2014	12-2013	12-2012	12-2006
Cash Flows From Operating Activities
Net Income	-8,388	-1,552	-3,683	-5,808	N/A
Depreciation Amortization	1	2	6	9	N/A
Accounts payable and accrued liabilities	-148	552	-96	26	N/A
Other Working Capital	1,018	1,468	2	176	N/A
Other Operating Activity	3,058	-1,421	813	375	0
Operating Cash Flow	$-4,459	$-951	$-2,958	$-5,222	$N/A

Cash Flows From Investing Activities
Other Investing Activity	-20	0	0	0	0
Investing Cash Flow	$-20	$N/A	$N/A	$N/A	$N/A

Cash Flows From Financing Activities
Debt Issued	N/A	1,756	1,460	34	N/A
Common Stock Issued	14,101	N/A	1	N/A	N/A
Other Financing Activity	-1,485	-1,143	0	-110	0
Financing Cash Flow	$12,616	$613	$1,461	$-75	$N/A

Exchange Rate Effect	90	3	25	-4	N/A
Beginning Cash Position	167	501	1,973	7,274	N/A
End Cash Position	8,394	167	501	1,973	N/A
Net Cash Flow	$8,227	$-334	$-1,472	$-5,301	$N/A

Free Cash Flow
Operating Cash Flow	-4,459	-951	-2,958	-5,222	N/A
Free Cash Flow	-4,459	-951	-2,958	-5,222	0